Mulders PF - Search Results

1

Mulders PF. Mulders PF. World J Urol. 2008 Apr;26(2):113. doi: 10.1007/s00345-008-0248-1. Epub 2008 Apr 4. World J Urol. 2008. PMID: 18389254 No abstract available.

2

The importance of prognostic factors in the individual treatment of patients with disseminated germ cell tumours.

Mulders PF, Oosterhof GO, Boetes C, de Mulder PH, Theeuwes AG, Debruyne FM. Mulders PF, et al. Br J Urol. 1990 Oct;66(4):425-9. doi: 10.1111/j.1464-410x.1990.tb14967.x. Br J Urol. 1990. PMID: 2224438

3

Tumor heterogeneity as prognostic factor in patients with low-stage (T1-3N0M0) renal-cell carcinoma.

van der Poel HG, Mulders PF, Oosterhof GO, Schaafsma HE, Hendriks JC, Schalken JA, Debruyne FM. van der Poel HG, et al. Among authors: mulders pf. Investig Urol (Berl). 1994;5:60-5. Investig Urol (Berl). 1994. PMID: 7719322 No abstract available.

4

Prognostic value of karyometric and clinical characteristics in renal cell carcinoma. Quantitative assessment of tumor heterogeneity.

van der Poel HG, Mulders PF, Oosterhof GO, Schaafsma HE, Hendriks JC, Schalken JA, Debruyne FM. van der Poel HG, et al. Among authors: mulders pf. Cancer. 1993 Nov 1;72(9):2667-74. doi: 10.1002/1097-0142(19931101)72:9<2667::aid-cncr2820720924>3.0.co;2-0. Cancer. 1993. PMID: 8402488

5

The role of adjuvant immunotherapy in renal cell carcinoma.

Mulders PF, De Mulder PH. Mulders PF, et al. Curr Urol Rep. 2002 Feb;3(1):44-9. doi: 10.1007/s11934-002-0010-y. Curr Urol Rep. 2002. PMID: 12084219 Review.

6

Re: Clinical role of f-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma.

Steffens MG, Mulders PF, Brouwers AH, Oyen WJ. Steffens MG, et al. Among authors: mulders pf. J Urol. 2002 Nov;168(5):2127-8. doi: 10.1016/S0022-5347(05)64320-0. J Urol. 2002. PMID: 12394731 No abstract available.

7

Vaccination of patients with metastatic renal cell carcinoma with autologous dendritic cells pulsed with autologous tumor antigens in combination with interleukin-2: a phase 1 study.

Oosterwijk-Wakka JC, Tiemessen DM, Bleumer I, de Vries IJ, Jongmans W, Adema GJ, Debruyne FM, de Mulder PH, Oosterwijk E, Mulders PF. Oosterwijk-Wakka JC, et al. Among authors: mulders pf. J Immunother. 2002 Nov-Dec;25(6):500-8. doi: 10.1097/00002371-200211000-00006. J Immunother. 2002. PMID: 12439347 Clinical Trial.

8

Immunotherapy for renal cell carcinoma.

Bleumer I, Oosterwijk E, De Mulder P, Mulders PF. Bleumer I, et al. Among authors: mulders pf. Eur Urol. 2003 Jul;44(1):65-75. doi: 10.1016/s0302-2838(03)00191-x. Eur Urol. 2003. PMID: 12814677 Review.

9

Targeting of adenovirus to human renal cell carcinoma cells.

Jongmans W, van den Oudenalder K, Tiemessen DM, Molkenboer J, Willemsen R, Mulders PF, Oosterwijk E. Jongmans W, et al. Among authors: mulders pf. Urology. 2003 Sep;62(3):559-65. doi: 10.1016/s0090-4295(03)00378-9. Urology. 2003. PMID: 12946777

10

Tumor antigens and markers in renal cell carcinoma.

Mulders P, Bleumer I, Oosterwijk E. Mulders P, et al. Urol Clin North Am. 2003 Aug;30(3):455-65. doi: 10.1016/s0094-0143(03)00024-7. Urol Clin North Am. 2003. PMID: 12953748 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

251 results

Search Page

Filters